Search

everythinglearnresearchcommunity

for

Search:↓

The document says that hair loss in women is often due to androgenic alopecia, similar to male baldness, and that hirsutism is treated with hormonal and cosmetic methods.

Methyl caprate greatly increases drug absorption through the skin and is better than other enhancers.

The document concludes that PCOS is a complex disorder caused by both genetic and environmental factors, affecting women's health in various ways, and requires personalized treatment.

Polycystic Ovary Syndrome (PCOS) is a common condition in women that can cause metabolic, reproductive, and psychological issues, and requires lifestyle changes and medication for management.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

Air pollution worsens skin diseases and aging by causing inflammation and oxidative stress.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

PCOS is caused by both genetics and environmental factors like diet and obesity.

Hormone treatments in transsexual individuals reduce hair growth and oil production in male-to-females and increase them in female-to-males.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Effective treatments for male pattern baldness include oral finasteride and topical minoxidil, while topical minoxidil is best for female pattern baldness.

Male pattern hair loss could hint at androgens affecting COVID-19 severity.

Men's sensitivity to male hormones might affect how severe COVID-19 gets for them.

The update highlights that non-classic congenital adrenal hyperplasia is common in women with excess male hormones, requires specific hormone tests for diagnosis, and has various treatment options depending on age and symptoms.

Lowering testosterone speeds up wound healing in male mice.

Hirsutism is more linked to high androgen levels than acne or hair loss, and a mix of hormonal tests is best for diagnosis; certain treatments can reduce symptoms.

Hair ages due to genetics and environmental factors, leading to graying and thinning, with treatments available for some conditions.

Mutant CDP/Cux protein causes hair defects and reduced male fertility in mice.

The conclusion is that early diagnosis and a multi-system treatment approach are crucial for managing PCOS and its associated health risks.

New hormonal contraceptives are safer, have fewer side effects, and offer health benefits for women.

Higher free testosterone levels in men are linked to a stronger immune response, not weaker.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

Hair loss in androgenetic alopecia is caused by genetic factors and androgen excess, and can be treated with combined therapies.

Some common medications can harm male fertility, but many effects can be reversed.

Finasteride, CPA, and flutamide are all equally effective in reducing excessive hair growth in women.

PCOS is a common hormonal disorder in women, treated with lifestyle changes and medications like hormonal contraceptives and metformin.

PCOS in teens is hard to diagnose, linked to genetics and lifestyle, and managed with weight loss and medication.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

People with polycystic ovary syndrome have a higher chance of having chronic thyroiditis.

Hormone treatment for transgender patients may not need to be stopped before surgery, but more research is needed, especially on estrogen.